ARS-1323-alkyne

CAS No. 2436544-27-1

ARS-1323-alkyne( —— )

Catalog No. M24120 CAS No. 2436544-27-1

ARS-1323-alkyne is a switch-II pocket (S-IIP) inhibitor and a conformational specific chemical reporter of KRASG12C nucleotide state in living cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 442 In Stock
10MG 746 In Stock
25MG 1102 In Stock
50MG 1460 In Stock
100MG 1972 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ARS-1323-alkyne
  • Note
    Research use only, not for human use.
  • Brief Description
    ARS-1323-alkyne is a switch-II pocket (S-IIP) inhibitor and a conformational specific chemical reporter of KRASG12C nucleotide state in living cells.
  • Description
    ARS-1323-alkyne is a switch-II pocket (S-IIP) inhibitor and a conformational specific chemical reporter of KRASG12C nucleotide state in living cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    Ras
  • Recptor
    KRAS G12C
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2436544-27-1
  • Formula Weight
    569
  • Molecular Formula
    C28H27ClF2N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:35.71 mg/mL (62.76 mM; Need ultrasonic)
  • SMILES
    O=C(C=C)N1CCN(C2=NC(NCCC(N(C)CC#C)=O)=NC3=C(F)C(C4=C(O)C=CC=C4F)=C(Cl)C=C23)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lou K,et al. KRASG12C inhibition produces a driver-limited state revealing collateral dependencies. Sci Signal. 2019 May 28;12(583). pii: eaaw9450.
molnova catalog
related products
  • K-Ras G12C-IN-3

    A novel and irreversible inhibitor of mutant K-ras G12C.

  • MRTX849

    MRTX849 is a potent selective and covalent KRASG12C inhibitor with potential antineoplastic activity.selectively modifies mutant cysteine 12 in GDP-bound KRASG12C and inhibits KRAS-dependent signaling.

  • SRJ-23

    A novel semisynthetic derivative of andrographolide that directly target Ras to block the exchange of GDP for GTP and thus prevent Ras activation.